Chronic terbutaline treatment desensitizes β-adrenergic inhibition of lymphocyte in activation in healthy volunteers

Journal of Autonomic Pharmacology

Volumn 17, Issue 4, 1997, Pages 237-242

  Werner, C ^a   Poller, U ^a   Brodde, O E ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CONCANAVALIN A; CYCLIC AMP; INOSITOL PHOSPHATE; ISOPRENALINE; TERBUTALINE;

CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE ACTIVATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RECEPTOR DOWN REGULATION;

EID: 0030784816     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1997.00458.x     Document Type: Conference Paper

References (37)

1. ALAVA, M.A., DEBELL, K.E., CONTI, A., HOFFMAN, T. & BONVIBI, E. (1992). Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor (CD3 complex) but not by G-protein stimulation. Biochem. J., 284, 189-199.
2. ANDERSON, J.L., CARLQIUST, J.F. & HAMMOND, E.H. (1982). Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet, II, 1124-1127.
3. BOURNE, H.R., LICHTENSTEIN, L.M., MELMON, K.L., HENNEY C.S, WEINSTEIN, Y. & SHEARER, G.M. (1974). Modulation of inflammation and immunity by cAMP: receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions. Science, 184, 19-28.
4. BöYUM, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21(suppl. 97), 77-89.
5. BRODDE, O.-E. & WANG, X.L. (1988). β-adrenoceptor changes in blood lymphocytes and altered drug responsiveness. Ann. Clin. Res., 20, 311-323.
6. BRODDE, O.-E., BECKERINGH, J.J. & MICHEL, M.C. (1987). Human heart β-adrenoceptors: a fair comparison with lymphocyte β-adrenoceptors? Trends Pharmacol. Sci., 8, 403-407.
7. 2-adrenoceptors. Accelerated restoration of β-adrenoceptor responsiveness by prednisone and ketotifen. J. Clin. Invest., 76, 1096-1101.
8. BRODDE, O.-E., MICHEL, M.C., GORODN, E.P., SANDOVAL, A., GILBERT, E.M. & BRISTOW, M.R. (1989). β-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? Eur. Heart J., 10(Suppl B), 2-10.
9. 2-adrenoceptors without Gi-protein alterations in human lymphocytes. J. Cardiovasc. Pharmacol., 20, 785-789.
10. CAMBIER, J.C., JUSTEMENT, L.B., NEWELL, M.K., CHEN, Z.Z., HARRIS, L.K., SANDOVAL, V.M., KLEMSZ, M.J. & RANSOM, J.T. (1987). Transmembrane signals and intracellular "second messengers" in the regulation of quiesent B-lymphocyte activation. Immunol. Rev., 95, 37-57.
11. CHEN, Z.Z., COGGESHALL, K.M. & CAMBIER, J.C. (1986). Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signalling in B lymphocytes. J. Immunol., 136, 2300-2304.
12. ECKSTEIN, R., MEMPEL, W. & BOLTE, H.D. (1982). Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circulation, 65, 1224-1229.
13. FOWLES, R.E., BIEBER, C.P. & STINSON, E.B. (1979). Defective in vitro suppressor cell function in idiopathic dilated cardiomyopathy. Circulation, 59, 483-491.
14. GOODWIN, J.S. & WEBB, D.R. (1980). Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol., 15, 106-122.
15. GUPTA, S. (1989). Mechanisms of transmembrane signalling in human T cell activation. Mol. Clin. Biochem., 91, 45-50.
16. HADDEN, J.W. (1988). Transmembrane signals in the activation of T lymphocytes by mitogenic antigens. Immunol. Today, 9, 235-239.
17. HARDEN, T.K. (1983). Agonist-induced desensitization of the beta- adrenergic receptor-linked adenylate cyclase. Pharmacol. Rev., 35, 5-32.
18. HAUSDORFF, W.P., CARON, M.G. & LEFKOWITZ, R.J. (1990). Turning off the signal: desensirization of β-adrenergic receptor function. FASEB J., 4, 2881-2889.
19. HELLSTRAND, K., HERMODSSON, S. & STRANNEGARD, O. (1985). Evidence for a beta-adrenoceptor mediated regulation of human natural killer cells. J. Immunol., 134, 4095-4099.
20. IMBODEN, J.B., SHOBACK, D.M., PATTISON, G. & STOBO, J.D. (1986). Cholera toxin inhibits the T-cell antigen receptor-mediated increase in inositol triphosphate and cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA, 83, 5673-5677.
21. KAMMER, G.M. (1988). The adenylate cyclase-cAMP-protein kinase A pathway and regulation of immune response. Immunol. Today, 9, 222-229.
22. LERNER, A., JACOBSON, B. & MILLER, R.A. (1988). Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse T lymphocytes. J. Immunol., 140, 936-940.
23. LIMAS, C.J., GOLDENBERG, I.F. & LIMAS, C. (1989). Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ. Res., 64, 97-103.
24. LOHSE, M.J. (1993). Molecular mechanisms of membrane-receptor desensitization. Biochim. Biophys. Acta, 1179, 171-188.
25. MADDEN, K.S., SANDERS, V.M. & FELTEN, D.L. (1995). Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol., 35, 417-448.
26. MAGHAZACHI, A.A. (1992). Cholera toxin inhibits interleukin-2-induced, but enhances pertussis toxin-induced T-cell proliferation: regulation by cyclic nucleotides. Immunology, 75, 103-107.
27. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest., 86, 1658-1663.
28. 1-adrenoceptor with positive chronotropic effect. Circulation, 89, 2760-2767.
29. MAISEL, A.S. & MOTULSKY, H.J. (1987). Receptor distribution does not accompany terbutaline-induced down-regulation of beta-adrenergic receptors on human mononuclear leukocytes. Clin. Pharmacol. Ther., 42, 100-106.
30. MAISEL, A.S., FOWLER, P., REARDEN, A., MOTULSKY, H.J. & MICHEL, M.C. (1989). A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther., 46, 429-439.
31. MAISEL, A.S., KNOWLTON, K.U., FOWLER, P., REARDEN, A., ZIEGLER, M.G., MOTULSKY, H.J., INSEL, P.A. & MICHEL, M.C. (1990). Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise and terbutaline treatment. J. Clin. Invest., 85, 462-467.
32. MOTULSKY, H.J. & INSEL, P.A. (1982). Adrenergic receptors in man. Direct identification, physiologic regulation and clinical alterations. N. Engl. J. Med., 307, 18-29.
33. SANDERSON, J.E., KOECH, D., IHA, D. & OJIAMBO, H.P. (1985). T-lymphocyte subsets in idiopathic dilated cardiomyopathy. Am. J. Cardiol., 55, 755-758.
34. SELLIAH, N., BARTIK, M.M., CARLSON, S.L., BROOKS, W.H., & ROSZMAN, T.L. (1995). cAMP accumulation in T-cells inhibits anti CD3-monoclonal antibody induced actinpolymerization. J. Neuroimmunol., 56(1), 107-112.
35. 2-adrenergic, spleen-dependent process. Am. J. Physiol., 258, E191-E202.
36. 2+-concentrations in human lymphocytes. Br. J. Pharmacol., 103, 1288-1294.
37. WINDEBANK, K.P., ABRAHAM, R.T., POWIS, G., OLSEN, R.A., BARNS, T J. & LEIBSON, P.J. (1988). Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation of cyclic AMP. J. Immunol., 141, 395-397.